Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9

Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis

Total article views   HTML views PDF downloads Totals
14,962 Dovepress* 13,816+ 1,905 15,721
PubMed Central* 1,146 229 1,375
Totals 14,962 2,134 17,096
*Since 10 January 2017
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 0 3

View citations on PubMed Central and Google Scholar